{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-048431","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2024-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.411674+00:00","generated_at":"2026-05-29T09:24:38.098495+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Protagenic Therapeutics appeals Nasdaq delisting; hearing set for Jan 30, 2025","bullets":["Nasdaq determined non-compliance with $2.5M stockholders' equity requirement (Rule 5550(b)(1)).","Company failed to regain compliance by Nov 18, 2024 extension deadline; delisting determination issued Nov 19.","Appeal filed Nov 27; hearing stayed pending Panel decision; hearing scheduled Jan 30, 2025.","Materials due Jan 10, 2025; no assurance Panel will grant more time to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-048431","json":"https://secwatch.observer/filing/0001493152-24-048431.json","markdown":"https://secwatch.observer/filing/0001493152-24-048431.md","text":"https://secwatch.observer/filing/0001493152-24-048431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/0001493152-24-048431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315224048431/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T09:24:38.098495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}